Results 71 to 80 of about 2,834,658 (290)
Observed frequencies (reporting probabilities) table for drug-drug-AE combinations.
Observed frequencies (reporting probabilities) table for drug-drug-AE combinations.
Inkyung Jung (94394) +1 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background and Aims Infant bone and soft tissue neoplasms present distinct clinical challenges and lack large‐scale data to inform treatment decisions. This study aims to characterize bone and soft tissue neoplasms in infants in Canada and to compare their outcomes with those of older pediatric patients.
Samuel Sassine +21 more
wiley +1 more source
Synlet map of known drug combinations.
, 2019 Fig 3 depicts synlet pairs addressed by drug combinations either already approved or in late stage clinical testing. Color-coded number tags indicate the twelve pairwise drug combinations. Synlet edges are displayed in red with drug target links shown in
Michael Schwarz (209306) +7 more
core +1 more source
Identifying mutant-specific multi-drug combinations using comparative network reconstruction
, 2022 Targeted inhibition of aberrant signaling is an important treatment strategy in cancer, but responses are often short-lived. Multi-drug combinations have the potential to mitigate this, but to avoid toxicity such combinations must be selective and given ...
Fernandes Neto, João M. +12 more
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Outcomes in relapsed or refractory pediatric and AYA bone sarcomas remain poor, and the impact of early referral to specialized sarcoma centers on survival is unclear. Early centralization of care may improve local and systemic treatment quality, but evidence in this population is limited.
Justyna Antoniuk‐Majchrzak +9 more
wiley +1 more source
PHARMACOECONOMIC ANALYSIS OF ANTIHYPERTENSIVE DRUG COMBINATIONS USE
Рациональная фармакотерапия в кардиологии, 2015 Aim. To pursue pharmacoeconomic analysis of two drug combinations of ACE inhibitor (enalapril) and diuretic.Material and methods. Patients with arterial hypertension degree 2 and diabetes mellitus type 2 without ischemic heart disease (n=56) were ...
E. I. Tarlovskaya +2 more
doaj +3 more sources
Summary of the drug combinations’ synergy data for different datasets.
, 2023 Summary of the drug combinations’ synergy data for different datasets.
Peng Zhang (2071), Shikui Tu (2610205)
core +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Central nervous system (CNS) relapse of neuroblastoma carries a poor prognosis, and craniospinal irradiation (CSI) poses substantial long‐term toxicity in young children. We report a toddler with MYCN‐amplified neuroblastoma harboring somatic ALK R1275Q who developed extensive leptomeningeal relapse with paraplegia.
Jinwoo Kim +11 more
wiley +1 more source
Summary of drug dosage and combinations reported.
, 2018 Summary of drug dosage and combinations reported.
Stephen Mason (2825816) +3 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Introduction Hyperlipidemia is a major risk factor for atherosclerotic cardiovascular disease (ASCVD). Although statins are the cornerstone of lipid‐lowering therapy, their use may be limited in some patients by adverse effects. This study evaluated the possible impact of non‐drug treatment using double‐filtration plasmapheresis (DFPP) on CD14+
Yun Cheng +3 more
wiley +1 more source